Member Info for BuenaVista

You're very observant!

Speaking of which, has anyone seen Captainstanley's tail recently?

OK, thanks

"In its FAP? activated form, the doxorubicin drug moiety is not cell permeable..."

Eh
Surely they mean

"In its FAPa substrate form, the doxorubicin drug moiety is not cell permeable..."

A lot of compounds were modified on Saturday. Could these be updates of previously described (as 'Created') compounds that are metabolites/breakdown compounds of AVA6000?

When you unearthed Toukmoron as Derek, do you remember the initials of the person?
And how sure are you that you weren't sold a dummy / fed a red herring / sent on a wildgoose chase?

How far from development, by which I suppose you mean regulatory approval, do you think it is Scottytom? What needs to happen to get it on the market?

Massive dumps?
355,287 Sell* was fat fingers
immediately reversed and 35,287 trade went through.

Actually replied to RonnieH

TheTwat has predicted 120p, then 130p then 160p (that post now gone) and is bashing hard today so I guess he's being paid to drive it down to 160p, his masters being surprised by the strong support on the way down having given up on getting it to 120/130. Who's wanting to get in low or is still short?

.

So HC have been selling some 1,657,000 of their 3,068,421 repayment allocation at £1.72 per share in order to self-fund the acquisition of 2,400,000 more shares?

HC received 3,068,421 on 24 January and will receive 2,400,000 on 16 February making 5,468,421 in total, which is less than 3% of Avacta shares in issue as of Thursday, so no TR1 required you moron.

Let me put it another way.

They haven't received enough to generate a TR1 you moron

They haven't received enough to generate a TR1 you moron

So in that case they wouldn't have done due diligence? £55m on favourable terms seems a big bet if based solely on information in the public domain.

Bloody autocorrect!

Those 3 large prints at the end of Friday are about £62.4k short of £2.85m FWIW. That shortfall could be elsewhere in the listing of traders of course. If HC, then they wouldn't have sold all their holding. This could be a self-funding way to add to their holding before Avacta starts repayments in cash.

But are HC allowed to trade whilst they are privy to market sensitive information, assuming DD? According to SB, no, and that makes sense as it would clearly be insider trading.

This instance yeboha you're the clown.

This wasn't a quarterly repayment. It was a decision by the loaner to convert some of the loan to shares at the conversion price, £1.1875.

At the quarterly repayment, Avacta has to cover to make the repayment in cash or shares. In future, even at the next repayment on 18 April, Avacta may be cash-rich enough to make the repayment in cash and the loaner would be locked out of receiving and further shares from the loan.

I regard that as extremely positive - licensing deal incoming!

I'll now go and have a laugh at what the basher clowns have been writing!